Abdominoplasty in a Patient With Type 3 von Willebrand Disease: A Case Report
- PMID: 37962210
- DOI: 10.1097/SAP.0000000000003711
Abdominoplasty in a Patient With Type 3 von Willebrand Disease: A Case Report
Abstract
von Willebrand disease (vWD) is an inherited bleeding disorder that is characterized by a quantitative or qualitative deficiency of the von Willebrand factor (vWF). Type 3 is the most severe form of vWD with a near-complete absence of vWF and a significantly increased risk of excessive bleeding and hematoma during a surgical procedure. To date, no data on surgical and hemostatic management of a type 3 vWD patient undergoing body-contouring surgery has been published. We report the case of a 47-year-old woman with type 3 vWD requiring medically indicated abdominoplasty after massive weight loss due to bariatric surgery. The case was successfully managed with individualized bodyweight-adapted substitution of recombinant vWF vonicog alfa and tranexamic acid under close monitoring of vWF and factor VIII activity. For further risk stratification, we propose the multidisciplinary treatment of patients with severe vWF undergoing elective plastic surgery in specialized centers providing around-the-clock laboratory testing and access to a blood bank. In addition, strict hemostasis during surgery and early postoperative mobilization with fitted compression garments are recommended to further reduce the risk of bleeding and thromboembolic complications.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest and sources of funding: none declared.
Similar articles
-
Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.J Cardiothorac Vasc Anesth. 2022 Mar;36(3):724-727. doi: 10.1053/j.jvca.2021.01.038. Epub 2021 Jan 27. J Cardiothorac Vasc Anesth. 2022. PMID: 33618961
-
Von Willebrand Disease.2009 Jun 4 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2009 Jun 4 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301765 Free Books & Documents. Review.
-
[Advances in the therapy for von Willebrand disease].Rinsho Ketsueki. 2023;64(5):389-396. doi: 10.11406/rinketsu.64.389. Rinsho Ketsueki. 2023. PMID: 37271530 Japanese.
-
Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment.Haemophilia. 2018 May;24(3):460-470. doi: 10.1111/hae.13451. Epub 2018 Mar 24. Haemophilia. 2018. PMID: 29573506
-
Von Willebrand's disease: case report and review of literature.Pan Afr Med J. 2017 Jun 29;27:147. doi: 10.11604/pamj.2017.27.147.12248. eCollection 2017. Pan Afr Med J. 2017. PMID: 28904675 Free PMC article. Review.
Cited by
-
Von Willebrand's disease in breast surgery: case report.J Surg Case Rep. 2024 Jun 4;2024(6):rjae395. doi: 10.1093/jscr/rjae395. eCollection 2024 Jun. J Surg Case Rep. 2024. PMID: 38835948 Free PMC article.
References
-
- Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med . 2004;351:683–694.
-
- Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood . 1987;69:454–459.
-
- Pietu G, Fressinaud E, Girma JP, et al. Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets. J Lab Clin Med . 1987;109:637–646.
-
- Miesbach W. Perioperative management for patients with von Willebrand disease: defining the optimal approach. Eur J Haematol . 2020;105:365–377.
-
- Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia . 2008;14:171–232.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous